TCL Archive NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study. June 3, 2005
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013
TCL Archive PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval. February 29, 2008
TCL Archive Natcher Subcommittee Objects To Budget Reductions, Squeeze From DeVita Details On Programs Being Cut March 15, 1985